Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Age-related aspects of cancer Quality of hospital and integrated care [ONCOL 2]"'
Autor:
Hendrika Boezen, M M de Jong, W.T.A. van der Graaf, Jelle Wesseling, Michael Schaapveld, Hermien Hartog
Publikováno v:
Breast, 22, 1155-60
Breast, 22, 6, pp. 1155-60
The Breast, 22(6), 1155-1160. Churchill Livingstone
Breast, 22, 6, pp. 1155-60
The Breast, 22(6), 1155-1160. Churchill Livingstone
Item does not contain fulltext High circulating insulin-like growth factor 1 (IGF-1) levels are firmly established as a risk factor for developing breast cancer, especially estrogen positive tumors. The effect of circulating IGF-1 on prognosis once a
Autor:
Johannes J. Bonenkamp, W.T.A. van der Graaf, Cees Verhoef, F. van Coevorden, Hans Gelderblom, R. Tielen, Stefan Sleijfer, J.H.W. de Wilt, Henk H. Hartgrink
Publikováno v:
European Journal of Surgical Oncology, 39, 2, pp. 150-5
European Journal of Surgical Oncology, 39, 150-5
European Journal of Surgical Oncology, 39(2), 150-155. W.B. Saunders
EJSO-European Journal of Surgical Oncology, 39(2), 150-155
European Journal of Surgical Oncology, 39, 150-5
European Journal of Surgical Oncology, 39(2), 150-155. W.B. Saunders
EJSO-European Journal of Surgical Oncology, 39(2), 150-155
Aims: Patients with locally advanced gastrointestinal stromal tumours (GISTs) have a high risk of tumour perforation, incomplete tumour resections and often require multivisceral resections. Long-term disease-free and overall survival is usually impa
Autor:
Heskamp, S., Boerman, O.C., Molkenboer-Kuenen, J.D.M., Oyen, W.J.G., Graaf, W.T.A. van der, Laarhoven, H.W.M. van
Publikováno v:
International Journal of Cancer, 133, 2, pp. 307-314
International Journal of Cancer, 133, 307-314
International Journal of Cancer, 133, 307-314
Item does not contain fulltext Bevacizumab (antivascular endothelial growth factor [anti-VEGF]) and cetuximab (antiepidermal growth factor receptor [anti-EGFR]) are approved antibodies for treatment of cancer. However, in advanced colorectal cancer,
Autor:
Jeroen van der Laak, Winette T. A. van der Graaf, J. Carlijn van Gaal, Gwen van der Heijden, Albert J. H. Suurmeijer, Uta Flucke, Eveline S. J. M. de Bont, Yvonne M.H. Versleijen-Jonkers, Melissa H.S. Roeffen
Publikováno v:
European Journal of Cancer, 49, 3462-70
European Journal of Cancer, 49, 16, pp. 3462-70
European Journal of Cancer, 49(16), 3462-3470. ELSEVIER SCI LTD
European Journal of Cancer, 49, 16, pp. 3462-70
European Journal of Cancer, 49(16), 3462-3470. ELSEVIER SCI LTD
Contains fulltext : 126252.pdf (Publisher’s version ) (Open Access) BACKGROUND: Rhabdomyosarcoma (RMS) is an aggressive soft tissue tumour mainly affecting children and adolescents. Since survival of high-risk patients remains poor, new treatment o
Autor:
Erik A.C. Wiemer, Walter J. Loos, Jaap Verweij, Martin N Fransson, Alex Sparreboom, An K.L. Reyners, Lena E. Friberg, Ugo De Giorgi, Karel Eechoute, Ron H.J. Mathijssen, Gaia Schiavon, Floris A. de Jong, Winette T. A. van der Graaf
Publikováno v:
Clinical Cancer Research, 18, 20, pp. 5780-5787
Clinical Cancer Research, 18, 5780-5787
Clinical Cancer Research, 18(20), 5780-5787. American Association for Cancer Research Inc.
Clinical Cancer Research, 18(20), 5780-5787. AMER ASSOC CANCER RESEARCH
Clinical Cancer Research, 18, 5780-5787
Clinical Cancer Research, 18(20), 5780-5787. American Association for Cancer Research Inc.
Clinical Cancer Research, 18(20), 5780-5787. AMER ASSOC CANCER RESEARCH
Purpose: Imatinib minimal (trough) plasma concentrations after one month of treatment have shown a significant association with clinical benefit in patients with gastrointestinal stromal tumors (GIST). Considering that a retrospective pharmacokinetic
Autor:
Gerhard A. Zielhuis, Katja K.H. Aben, Nienke A van Gils, Winette T. A. van der Graaf, J. Carlijn van Gaal
Publikováno v:
Acta Oncologica, 51, 922-33
Acta Oncologica, 51, 7, pp. 922-33
Acta Oncologica, 51, 7, pp. 922-33
Item does not contain fulltext Abstract Background. Cancer among adolescents and young adults (AYAs; 15-29 years old) is relatively rare but its incidence is increasing worldwide. To define the extent and nature of the AYA patients, this population-b
Autor:
Winette T. A. van der Graaf, Coby Meijer, Gert Jan Meersma, Ed Schuuring, Jaap van Doorn, Bart Rikhof, Steven de Jong, Albert J. H. Suurmeijer, Patricia J. T. A. Groenen
Publikováno v:
American Journal of Pathology, 181, 303-12
American Journal of Pathology, 181, 1, pp. 303-12
American Journal of Pathology, 181(1), 303-312. ELSEVIER SCIENCE INC
American Journal of Pathology, 181, 1, pp. 303-12
American Journal of Pathology, 181(1), 303-312. ELSEVIER SCIENCE INC
Contains fulltext : 109924.pdf (Publisher’s version ) (Closed access) New treatment targets need to be identified in gastrointestinal stromal tumors (GISTs) to extend the treatment options for patients experiencing failure with small-molecule tyros
Publikováno v:
Current Treatment Options in Oncology, 13, 306-17
Current Treatment Options in Oncology
Current Treatment Options in Oncology, 13, 3, pp. 306-17
Current Treatment Options in Oncology, 13(3), 306-317
Current Treatment Options in Oncology
Current Treatment Options in Oncology, 13, 3, pp. 306-17
Current Treatment Options in Oncology, 13(3), 306-317
Item does not contain fulltext OPINION STATEMENT: The outcome of patients with advanced soft tissue sarcomas (STS) has not improved much during the last decade. Apart from non-pleomorphic rhabdomyosarcoma, adjuvant chemotherapy has no standard role i
Autor:
J. Carlijn van Gaal, Winette T. A. van der Graaf, Suzanne E. J. Kaal, Eveline S. J. M. de Bont, Yvonne M.H. Versleijen-Jonkers
Publikováno v:
Critical Reviews in Oncology Hematology, 82, 3, pp. 259-79
Critical Reviews in Oncology Hematology, 82, 259-79
Critical Reviews in Oncology Hematology, 82, 259-79
Rhabdomyosarcoma (RMS) is a rare type of soft tissue sarcoma that mainly affects children, but also occurs in adolescents and (young) adults (AYA). Despite dramatic survival improvements reported by international study groups in children over the pas
Autor:
Winette T. A. van der Graaf, Eveline S. J. M. de Bont, Albert J. H. Suurmeijer, Melissa H.S. Roeffen, Yvonne M.H. Versleijen-Jonkers, Annelies M. C. Mavinkurve-Groothuis, J. Carlijn van Gaal, Uta Flucke, Stefan Sleijfer
Publikováno v:
Journal of Clinical Oncology, 30(3), 308-315. American Society of Clinical Oncology
Journal of Clinical Oncology, 30, 3, pp. 308-15
Journal of Clinical Oncology, 30, 308-15
Journal of Clinical Oncology, 30(3), 308-315. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 30, 3, pp. 308-15
Journal of Clinical Oncology, 30, 308-15
Journal of Clinical Oncology, 30(3), 308-315. AMER SOC CLINICAL ONCOLOGY
Purpose The aim of this study is to investigate anaplastic lymphoma kinase (ALK) protein expression and underlying genetic aberrations in rhabdomyosarcoma (RMS), with special attention to clinical and prognostic implications. Patients and Methods A t